diaendoСахарный диабетDiabetes mellitus2072-03512072-0378Endocrinology research centre10.14341/DM2013428-32diaendo-6293Research ArticleВопросы патогенезаPathogenesisАутоиммунные маркеры заболеваний желудочно-кишечного тракта у пациентов с сахарным диабетом 1 типаMarkers for gastrointestinal autoimmune disorders in patients with type 1 diabetes mellitusДеревянкоОльга СергеевнаDerevyankoOlga Sergeevna

аспирант отделения программного обучения и лечения Института диабета

postgraduate student

shapovalyants@yahoo.comДалантаеваНадежда СергеевнаDalantaevaNadezhda Sergeevna

аспирант отделения нейроэндокринологии и остеопатий Института клинической эндокринологии

postgraduate student

post@endocrincentr.ruПекареваЕлена ВладимировнаPekarevaElena Vladimirovna

кандидат медицинских наук, старший научный сотрудник отделения программного обучения и лечения Института диабета

MD, PhD, Senior Researcher in Diabetic Education and treatment department

pekarevaev@mail.ruИвановаОльга НиколаевнаIvanovaOlga Nikolaevna

кандидат биологических наук, ведущий научный сотрудник, заведующий лабораторнии генетики и клинической иммуннологии

PhD, Leading Researcher, Head of genetic and clinical immunology laboratory

post@endocrincentr.ruГончаровНиколай ПетровичGoncharovNikolay Petrovich

доктор медицинских наук, профессор, руководитель лаборатории гормонального анализа

MD, PhD, Professor, Head of laboratory for hormone analisis

post@endocrincentr.ruНиконоваТатьяна ВасильевнаNikonovaTatiana Vasil'evna

доктор медицинских наук, ведущий научный сотрудник отделения программного обучения и лечения Института диабета

MD, PhD, Leading Researcher in Diabetic education and treatment department

tatiana_nikonova@mail.ruСмирноваОльга МихайловнаSmirnovaOlga Mikhailovna

доктор медицинских наук, профессор, главный научный сотрудник отделения программного обучения и лечения Института диабета

MD, PhD, Professor, Chief Researcher in Diabetic education and treatment department

dr_smr@mail.ruФГБУ Эндокринологический научный центр, МоскваРоссияEndocrinology Research Centre, MoscowRussian Federation2013181220131642832Copyright © Деревянко О.С., Далантаева Н.С., Пекарева Е.В., Иванова О.Н., Гончаров Н.П., Никонова Т.В., Смирнова О.М., 20132013Деревянко О.С., Далантаева Н.С., Пекарева Е.В., Иванова О.Н., Гончаров Н.П., Никонова Т.В., Смирнова О.М.Derevyanko O.S., Dalantaeva N.S., Pekareva E.V., Ivanova O.N., Goncharov N.P., Nikonova T.V., Smirnova O.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.dia-endojournals.ru/jour/article/view/6293сахарный диабет 1 типааутоиммунный гастритаутоиммунный панкреатитtype 1 diabetes mellitusautoimmune gastritisautoimmune pancreatitisReferencesWägner AM, Santana Á, Herńndez M, Wiebe JC, Nóvoa J, Mauricio D, The TD. Predictors of associated autoimmune diseases in families with type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium. Diabetes Metab Res Rev. 2011;27(5):493–498.Wägner AM, Santana Á, Herńndez M, Wiebe JC, Nóvoa J, Mauricio D, The TD. Predictors of associated autoimmune diseases in families with type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium. Diabetes Metab Res Rev. 2011;27(5):493–498.doi: 10.1002/dmrr.1189doi: 10.1002/dmrr.1189Triolo TM, Armstrong TK, McFann K, Yu L, Rewers MJ, Klingensmith GJ, Eisenbarth GS, Barker JM. Additional Autoimmune Disease Found in 33% of Patients at Type 1 Diabetes Onset. Diabetes Care. 2011 May 1, 2011;34(5):1211–1213.Triolo TM, Armstrong TK, McFann K, Yu L, Rewers MJ, Klingensmith GJ, Eisenbarth GS, Barker JM. Additional Autoimmune Disease Found in 33% of Patients at Type 1 Diabetes Onset. Diabetes Care. 2011 May 1, 2011;34(5):1211–1213.DOI: 10.2337/dc10-1756DOI: 10.2337/dc10-1756Barker JM. Type 1 Diabetes-Associated Autoimmunity: Natural History, Genetic Associations, and Screening. J Clin Endocrinol Metab. 2006 April 1, 2006;91(4):1210–1217.Barker JM. Type 1 Diabetes-Associated Autoimmunity: Natural History, Genetic Associations, and Screening. J Clin Endocrinol Metab. 2006 April 1, 2006;91(4):1210–1217.DOI: 10.1210/jc.2005-1679DOI: 10.1210/jc.2005-1679Маев ИВ, Кучерявый ЮА, Оганесян ТС. Аутоиммунный панкреатит: современное состояние проблемы. Терапевтический архив. 2012;84(2):56–61. [Maev IV, Kucheryavy YuA, Oganesyan TS. Autoimmune pancreatitis: current status. Terapevticheskiy arkhiv. 2012;84(2):56–61.]Маев ИВ, Кучерявый ЮА, Оганесян ТС. Аутоиммунный панкреатит: современное состояние проблемы. Терапевтический архив. 2012;84(2):56–61. [Maev IV, Kucheryavy YuA, Oganesyan TS. Autoimmune pancreatitis: current status. Terapevticheskiy arkhiv. 2012;84(2):56–61.]Takuma K, Kamisawa T, Gopalakrishna R, Hara S, Tabata T, Inaba Y, Egawa N, Igarashi Y. Strategy to differentiate autoimmune pancreatitis from pancreas cancer. World J Gastroenterol. 2012 Mar 14;18(10):1015–1020.Takuma K, Kamisawa T, Gopalakrishna R, Hara S, Tabata T, Inaba Y, Egawa N, Igarashi Y. Strategy to differentiate autoimmune pancreatitis from pancreas cancer. World J Gastroenterol. 2012 Mar 14;18(10):1015–1020.DOI: 10.3748/wjg.v18.i10.1015DOI: 10.3748/wjg.v18.i10.1015Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, Kim M-H, Klöppel G, Lerch MM, Löhr M, Notohara K, Okazaki K, Schneider A, Zhang L. International Consensus Diagnostic Criteria for Autoimmune Pancreatitis: Guidelines of the International Association of Pancreatology. Pancreas. 2011;40(3):352–358.Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, Kim M-H, Klöppel G, Lerch MM, Löhr M, Notohara K, Okazaki K, Schneider A, Zhang L. International Consensus Diagnostic Criteria for Autoimmune Pancreatitis: Guidelines of the International Association of Pancreatology. Pancreas. 2011;40(3):352–358.DOI: 10.1097/MPA.0b013e3182142fd2DOI: 10.1097/MPA.0b013e3182142fd2Smyk DS, Rigopoulou EI, Koutsoumpas AL, Kriese S, Burroughs AK, Bogdanos DP. Autoantibodies in Autoimmune Pancreatitis. International Journal of Rheumatology. 2012;2012:8.Smyk DS, Rigopoulou EI, Koutsoumpas AL, Kriese S, Burroughs AK, Bogdanos DP. Autoantibodies in Autoimmune Pancreatitis. International Journal of Rheumatology. 2012;2012:8.DOI: 10.1155/2012/940831DOI: 10.1155/2012/940831Barrett S, Riordon A, Toh B. Homing and adhesion molecules in autoimmune gastritis. J. Leukoc. Biol. 2000; 67:169–173.Barrett S, Riordon A, Toh B. Homing and adhesion molecules in autoimmune gastritis. J. Leukoc. Biol. 2000; 67:169–173.De Block CEM, De Leeuw IH, Van Gaal LF. Autoimmune Gastritis in Type 1 Diabetes: A Clinically Oriented Review. J Clin Endocrinol Metab. 2008 February 1, 2008;93(2):363–371.De Block CEM, De Leeuw IH, Van Gaal LF. Autoimmune Gastritis in Type 1 Diabetes: A Clinically Oriented Review. J Clin Endocrinol Metab. 2008 February 1, 2008;93(2):363–371.DOI: 10.1210/jc.2007-2134DOI: 10.1210/jc.2007-2134De Block CEM, De Leeuw IH, Bogers JJPM, Pelckmans PA, Ieven MM, Van Marck EAE, Van Acker KL, Van Gaal LF. Autoimmune Gastropathy in Type 1 Diabetic Patients With Parietal Cell Antibodies: Histological and clinical findings. Diabetes Care. 2003 January 1, 2003;26(1):82–88.De Block CEM, De Leeuw IH, Bogers JJPM, Pelckmans PA, Ieven MM, Van Marck EAE, Van Acker KL, Van Gaal LF. Autoimmune Gastropathy in Type 1 Diabetic Patients With Parietal Cell Antibodies: Histological and clinical findings. Diabetes Care. 2003 January 1, 2003;26(1):82–88.DOI: 10.2337/diacare.26.1.82DOI: 10.2337/diacare.26.1.82Vanoli A, La Rosa S, Luinetti O, Klersy C, Manca R, Alvisi C, Rossi S, Trespi E, Zangrandi A, Sessa F, Capella C, Solcia E. Histologic changes in type A chronic atrophic gastritis indicating increased risk of neuroendocrine tumor development: the predictive role of dysplastic and severely hyperplastic enterochromaffin-like cell lesions. Hum Pathol. 2013 May 2.Vanoli A, La Rosa S, Luinetti O, Klersy C, Manca R, Alvisi C, Rossi S, Trespi E, Zangrandi A, Sessa F, Capella C, Solcia E. Histologic changes in type A chronic atrophic gastritis indicating increased risk of neuroendocrine tumor development: the predictive role of dysplastic and severely hyperplastic enterochromaffin-like cell lesions. Hum Pathol. 2013 May 2.DOI: 10.1016/j.humpath.2013.02.005.DOI: 10.1016/j.humpath.2013.02.005.Shu X, Ji J, Li X, Sundquist J, Sundquist K, Hemminki K. Cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population-based cohort study in Sweden. Diabet Med. 2010;27(7):791–797.Shu X, Ji J, Li X, Sundquist J, Sundquist K, Hemminki K. Cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population-based cohort study in Sweden. Diabet Med. 2010;27(7):791–797.DOI: 10.1111/j.1464-5491.2010.03011.xDOI: 10.1111/j.1464-5491.2010.03011.xKnip M, Korhonen S, Kulmala P, Veijola R, Reunanen A, Raitakari OT, Viikari J, Åkerblom HK. Prediction of Type 1 Diabetes in the General Population. Diabetes Care. 2010 June 1, 2010;33(6):1206–1212.Knip M, Korhonen S, Kulmala P, Veijola R, Reunanen A, Raitakari OT, Viikari J, Åkerblom HK. Prediction of Type 1 Diabetes in the General Population. Diabetes Care. 2010 June 1, 2010;33(6):1206–1212.DOI: 10.2337/dc09-1040DOI: 10.2337/dc09-1040

The authors declare that there are no conflicts of interest present.